Recombinant Activated Factor VII for False Aneurysms in Patients with Normal Haemostatic Mechanisms

• References

• 1 Pressler V, McNamara JJ. Thoracic aortic aneurysm: natural history and treatment. J Thorac Cardiovasc Surg 1980; 79: 489-98.
• 2 Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331: 1729-34.
• 3 Hedner U, Glazer S, Pingel K, Alberts KA, Blombäck M, Schulman S, Johnsson H. Successful use of recombinant factor VIIa in a patient with severe hemophilia A during synovectomy. Lancet 1988; ii: 1193
• 4 Meijer K, Sieders E, Slooff MJH, de Wolf, van der Meer J. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII. Thromb Haemost 1998; 80: 204-5.
• 5 Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coag Fibrinol 1998; 9 (Suppl. 01) 147-52.
• 6 Ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa is mediated by tissue factor. J Clin Invest 1993; 92: 1207-12.